Eurofins Viracor BioPharma Services provides highly sensitive, clinically validated respiratory pathogen testing to support clinical trials, vaccine development, therapeutic studies, and surveillance programs. With more than 35 years of infectious disease expertise, we deliver the speed, accuracy, and scientific partnership needed to advance your respiratory research.
Our extensive portfolio includes singleplex and multiplex assays designed to detect a wide range of viral and bacterial pathogens, including:
SARS‑CoV‑2
Influenza A and B
RSV A and B
Human metapneumovirus
Rhinovirus/enterovirus
Parainfluenza viruses
Adenovirus
Bordetella species
Mycoplasma pneumoniae and Chlamydophila pneumoniae
Assays are available in quantitative and qualitative formats to support diverse study endpoints, from detection to viral load monitoring.
Our laboratories leverage advanced molecular methods, including PCR, qPCR, and NGS-based detection, delivering:
Highly sensitive and specific results
Rapid turnaround times to keep trials moving
Robust performance across sample types
Validated, reproducible data you can trust
Our deep infectious disease experience ensures scientific rigor in every test, from assay validation to result interpretation.
Our scientists and study management teams collaborate closely with sponsors to design testing strategies aligned with study objectives, regulatory expectations, and operational timelines. Capabilities include:
Custom assay development and optimization
Support for Phase I–IV trials
Central lab services integrated with global logistics
Data management, customized reporting, and regulatory documentation
Whether your program requires rapid screening, pathogen load trending, or exploratory biomarker analysis, we provide flexible, end‑to‑end support.
Decades of respiratory pathogen expertise
Proven performance in high-volume, high-complexity testing
CLIA-certified laboratory
Quality systems built for biopharma expectations
A partner trusted by leading pharmaceutical companies and diagnostic developers
We combine scientific excellence with operational reliability, accelerating your respiratory research with actionable, high‑quality data.